Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MK2a inhibitor is a substrate-selective inhibitor of p38α MAPK that selectively inhibits p38α-dependent phosphorylation of MAPKAPK-2 (MK2) over activating transcription factor 2 (ATF2; Ki = 330 and >20,000 nM, respectively, in cell-free assays).1 It inhibits proliferation of U87, A172, and U251 glioblastoma cells (EC50s = 0.6-1 μM) via inhibition of tubulin polymerization and induction of apoptosis.2
WARNING This product is not for human or veterinary use.
1. Discovery and characterization of a substrate selective p38α inhibitor. Biochemistry 43(37), 11658-11671 (2004).
2. Deciphering the true antiproliferative target of an MK2 activation inhibitor in glioblastoma. Cell Death Dis. e2069, (2016).